SCOPUS 정보 검색 플랫폼

Human Reproduction

Volumn 16, Issue 12, 2001, Pages 2557-2562

The cost-effectiveness of IVF in the UK: A comparison of three gonadotrophin treatments

(4) Sykes, David a Out, Henk J a Palmer, Stephen J b Van Loon, Jeanni c

a MERCK RESEARCH LABORATORIES (United States)

b UNIVERSITY OF YORK (United Kingdom)

c Quathos (Netherlands)

Author keywords

Cost effectiveness; HMG; IVF; rFSH; uFSH

Indexed keywords

GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISEASE ASSOCIATION; DRUG COST; FEMALE; FERTILIZATION IN VITRO; HEALTH CARE MANAGEMENT; HUMAN; INFERTILITY; MEDICAL LITERATURE; MENSTRUAL CYCLE; MODEL; NATIONAL HEALTH SERVICE; OVULATION; OVULATION INDUCTION; PREDICTION; PREGNANCY; PREGNANCY RATE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 0035652313 PISSN: 02681161 EISSN: None Source Type: Journal
DOI: 10.1093/humrep/16.12.2557 Document Type: Article

Times cited : (52)

References (23)

1
- 0033983137
- Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: A meta-analysis
- (2000) Fertil. Steril. , vol.73 , pp. 338-343
- Agrawal, R.¹ Holmes, J.² Jacobs, H.S.³

2
- 0030778063
- Recombinant human follicle stimulating hormone (r-hFSH, Gonal-F) versus highly purified urinary FSH (Metrodin HP) - Results of a randomized comparative study in women undergoing assisted reproductive techniques
- (1997) Hum. Reprod. , vol.12 , pp. 2133-2139
- Bergh, C.¹ Howles, C.M.² Borg, K.³

3
- 0029365369
- Sensitivity analysis in economic evaluation: A review of published studies
- (1995) Health Econ. , vol.4 , pp. 355-371
- Briggs, A.H.¹ Sculpher, M.J.²

4
- 0030840642
- Modelling in economic evaluation: An unavoidable fact of life
- (1997) Health Econ. , vol.6 , pp. 217-227
- Buxton, M.J.¹ Drummond, M.F.² Van Hout, B.A.³

5
- 0034566280
- Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles
- (Cochrane Review); Update Software, Oxford
- (2000) The Cochrane Library , Issue.4
- Daya, S.¹ Gunby, J.²

6
- 0029015244
- Follicle-stimulating hormone versus human menopausal gonadotrophin for in vitro fertilization cycles: A meta-analysis
- (1995) Fertil. Steril. , vol.64 , pp. 347-354
- Daya, S.¹ Gunby, J.² Hughes, E.G.³

7
- 0028266774
- Infertility prevalence, needs assessment and purchasing
- (1994) J. Publ. Health Med. , vol.16 , pp. 29-35
- Gunnell, D.J.¹ Ewings, P.²

8
- 1842371504
- Cryopreservation: The practicalities of evaluation
- (1997) Hum. Reprod. , vol.12 , pp. 1522-1524
- Jones H.W., Jr.¹ Out, H.J.² Hoomans, E.H.M.³

9
- 0032917595
- Pharmaco-economic effects of in-vitro fertilization in Italy
- (1999) Hum. Reprod. , vol.14 , pp. 953-958
- Mantovani, L.G.¹ Belisari, A.² Szucs, T.D.³

10
- 0033142551
- What are the benefits of recombinant gonadotrophins? Is Puregon a 'good' or 'super' drug?
- (1999) Hum. Reprod. , vol.14 , pp. 1409-1411
- Meniru, G.L.¹

11
- 0028812717
- A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle-stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization
- (1995) Hum. Reprod. , vol.10 , pp. 2534-2540
- Out, H.J.¹ Mannaerts, B.M.J.L.² Driessen, S.G.A.J.³

12
- 0029973840
- Recombinant follicle stimulating hormone (rFSH, Puregon) in assisted reproduction: More oocytes, more pregnancies. Results from five comparative studies
- (1996) Hum. Reprod. Update , vol.2 , pp. 162-171
- Out, H.J.¹ Mannaerts, B.M.J.L.² Driessen, S.G.A.J.³

13
- 0033963346
- Increasing the daily dose of recombinant follicle-stimulating hormone (Puregon®) does not compensate for the age-related decline in retrievable oocytes after controlled ovarian hyperstimulation
- (2000) Hum. Reprod. , vol.15 , pp. 29-35
- Out, H.J.¹ Braat, D.D.M.² Lintsen, B.M.E.³

14
- 33749783374
- Metrodin® and Metrodin XP™: Comparative dynamics of folliculogenesis and the estrogen response
- (1996) Fertil. Steril. , vol.66 , Issue.SUPPL. 1
- O'Dea, L.¹ Banks, K.²

15
- 0033971874
- Evaluation of the relative cost-effectiveness of treatment for subfertility
- (2000) Hum. Reprod. , vol.15 , pp. 96-106
- Philips, Z.¹ Barraza-Llorens, M.² Posnett, J.³

16
- 0003715375
- Royal College of Obstetricians and Gynaecologists
- (1998) The Initial Investigation and Management of the Infertile Couple

17
- 0003715370
- Royal College of Obstetricians and Gynaecologists
- (1998) The Management of Infertility in Secondary Care

18
- 0003785592
- Royal College of Obstetricians and Gynaecologists
- (2000) The Management of Infertility in Tertiary Care

19
- 0026332051
- Infertility-epidemiology and referral practice
- (1991) Hum. Reprod. , vol.6 , pp. 1391-1394
- Templeton, A.¹ Fraser, C.² Thompson, B.³

20
- 0030599530
- Factors that affect outcome of in vitro fertilization treatment
- (1996) Lancet , vol.348 , pp. 1402-1406
- Templeton, A.¹ Morris, J.K.² Parslow, W.³

21
- 0030052869
- Marginal costs and benefits
- (1996) Br. Med. J. , vol.312 , pp. 35-36
- Torgerson, D.J.¹ Spencer, A.²

22
- 85056986084
- Cost-effectiveness analysis of Puregon in comparison to Metrodin HP in in vitro fertilisation (IVF) in the Netherlands
- (1998) Fertil. Steril. , vol.70 , Issue.SUPPL. 1
- Van Loon, J.M.¹

23
- 0003726606
- W.B. Saunders Co., Philadelphia
- (1980) Clinical Decision Analysis
- Weinstein, M.C.¹ Fineberg, H.V.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.